Correlation Between Collegium Pharmaceutical and Akanda Corp
Can any of the company-specific risk be diversified away by investing in both Collegium Pharmaceutical and Akanda Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Collegium Pharmaceutical and Akanda Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Collegium Pharmaceutical and Akanda Corp, you can compare the effects of market volatilities on Collegium Pharmaceutical and Akanda Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Collegium Pharmaceutical with a short position of Akanda Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Collegium Pharmaceutical and Akanda Corp.
Diversification Opportunities for Collegium Pharmaceutical and Akanda Corp
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Collegium and Akanda is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Collegium Pharmaceutical and Akanda Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akanda Corp and Collegium Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Collegium Pharmaceutical are associated (or correlated) with Akanda Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akanda Corp has no effect on the direction of Collegium Pharmaceutical i.e., Collegium Pharmaceutical and Akanda Corp go up and down completely randomly.
Pair Corralation between Collegium Pharmaceutical and Akanda Corp
Given the investment horizon of 90 days Collegium Pharmaceutical is expected to generate 0.51 times more return on investment than Akanda Corp. However, Collegium Pharmaceutical is 1.96 times less risky than Akanda Corp. It trades about -0.13 of its potential returns per unit of risk. Akanda Corp is currently generating about -0.08 per unit of risk. If you would invest 3,742 in Collegium Pharmaceutical on September 1, 2024 and sell it today you would lose (692.00) from holding Collegium Pharmaceutical or give up 18.49% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Collegium Pharmaceutical vs. Akanda Corp
Performance |
Timeline |
Collegium Pharmaceutical |
Akanda Corp |
Collegium Pharmaceutical and Akanda Corp Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Collegium Pharmaceutical and Akanda Corp
The main advantage of trading using opposite Collegium Pharmaceutical and Akanda Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Collegium Pharmaceutical position performs unexpectedly, Akanda Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akanda Corp will offset losses from the drop in Akanda Corp's long position.The idea behind Collegium Pharmaceutical and Akanda Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Akanda Corp vs. Tff Pharmaceuticals | Akanda Corp vs. Eliem Therapeutics | Akanda Corp vs. Inhibrx | Akanda Corp vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Fundamental Analysis View fundamental data based on most recent published financial statements |